Certificate of Analysis
GLP-3 (RT)
Values below are transcribed from the signed certificate for each lot, issued by an independent laboratory, named on each lot. Each certificate covers one vial size. They describe the material’s identity and purity only.
60 mg — lot YU60-6P-C
| Compound identity | Retatrutide |
|---|---|
| Variant | GLP-3 (RT) · 60 mg |
| Lot number | YU60-6P-C |
| Labeled amount | 60 mg |
| Assayed net peptide | 63.78 mg |
| Purity (HPLC) | 99.98% |
| Date tested | Nov 7, 2026 |
| Issuing laboratory | Freedom Diagnostics |
| Verification code | VNGL2611044223 (look it up at freedomdiagnosticstesting.com) |
10 mg — lot RET1025
| Compound identity | Retatrutide |
|---|---|
| Variant | GLP-3 (RT) · 10 mg |
| Lot number | RET1025 |
| Labeled amount | 10 mg |
| Assayed net peptide | 10.55 mg |
| Purity (HPLC) | 99.72% |
| Date tested | Dec 19, 2025 |
| Sterility (USP <71>) | No growth detected |
| Bacterial endotoxin (LAL) | < 0.05 EU/mg |
| Heavy metals (ICP-MS) | Screened — Cr, As, Cd, Pb, Hg |
| Issuing laboratory | Vanguard Laboratory |
| Accreditation | ISO/IEC 17025 (A2LA cert #6377.01.01) |
Sold as GLP-3 (RT). Compound identity on the certificate: retatrutide.
Not yet published for: 20mg, 30mg.
Research use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.
